Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised by chronic,
progressive scarring of the lungs and the pathological hallmark of usual interstitial …

Progressive fibrosing interstitial lung diseases (ILDs) involve similar pathophysiological
processes, indicating the potential for common approaches to treatment. Nintedanib …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease with limited
therapeutic options, and there is a huge unmet need for new therapies. A growing body of …

Significance: Idiopathic pulmonary fibrosis (IPF) is a progressive age-related lung disease
with a median survival of only 3 years after diagnosis. The pathogenic mechanisms behind …

Idiopathic pulmonary fibrosis is a progressive fibrosing interstitial lung disease for which
there is no known cure. Currently available therapeutic options have been shown at best to …

Background Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a poor
prognosis. Pirfenidone is the first antifibrotic agent to be approved for IPF-treatment as it is …

Uterine fibroids (UFs) are the most common tumors of the female genital tract. The effect of
UFs on the quality of life and the overall cost of treatment are significant issues worldwide …

Background: Shuangshen Pingfei San (SPS) is the derivative from the classic formula
Renshen Pingfei San in treating idiopathic pulmonary fibrosis (IPF). Methods: In this study …

The most memorable part of my San Francisco trip was stopping at the crest of each hill,
small or large, to “admire the view.” In truth, my legs were leaden and I was gasping for air …

Fibrosis is defined as the excessive accumulation and disorganized deposition of
extracellular matrix components, affecting any organ in the human body. Fibrotic diseases of …